The principal difference in the pharmacological viewpoints between donepezil and rivastigmine concerns their therapeutic uses for mild to moderate AD, such that donepezil is AChE selective, while rivastigmine acts on both AChE and butyrylcholinesterase (BuChE). The gene discussed is ACHE; the disease is Alzheimer disease.